Uzzo RG - Search Results

1

Radiation dose and late failures in prostate cancer.

Morgan PB, Hanlon AL, Horwitz EM, Buyyounouski MK, Uzzo RG, Pollack A. Morgan PB, et al. Among authors: uzzo rg. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1074-81. doi: 10.1016/j.ijrobp.2006.10.023. Epub 2006 Dec 29. Int J Radiat Oncol Biol Phys. 2007. PMID: 17197131 Free PMC article.

2

Decision-making strategies for patients with localized prostate cancer.

Diefenbach MA, Dorsey J, Uzzo RG, Hanks GE, Greenberg RE, Horwitz E, Newton F, Engstrom PF. Diefenbach MA, et al. Among authors: uzzo rg. Semin Urol Oncol. 2002 Feb;20(1):55-62. doi: 10.1053/suro.2002.30399. Semin Urol Oncol. 2002. PMID: 11828358

3

Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy.

Pinover WH, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE. Pinover WH, et al. Among authors: uzzo rg. Cancer. 2003 Feb 15;97(4):1127-33. doi: 10.1002/cncr.11166. Cancer. 2003. PMID: 12569615 Free article.

4

Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants.

Horwitz EM, Mitra RK, Uzzo RG, Das IJ, Pinover WH, Hanlon AL, McNeeley SW, Hanks GE. Horwitz EM, et al. Among authors: uzzo rg. Radiother Oncol. 2003 Feb;66(2):173-9. doi: 10.1016/s0167-8140(02)00387-0. Radiother Oncol. 2003. PMID: 12648789

5

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.

Uzzo RG, Pinover WH, Horwitz EM, Parlanti A, Mazzoni S, Raysor S, Mirchandani I, Greenberg RE, Pollack A, Hanks GE, Watkins-Bruner D. Uzzo RG, et al. Urology. 2003 Apr;61(4):754-9. doi: 10.1016/s0090-4295(02)02524-4. Urology. 2003. PMID: 12670560

6

Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone.

Horwitz EM, Uzzo RG, Hanlon AL, Greenberg RE, Hanks GE, Pollack A. Horwitz EM, et al. Among authors: uzzo rg. J Urol. 2003 Jun;169(6):2153-7; discussion 2157-9. doi: 10.1097/01.ju.0000067181.52741.09. J Urol. 2003. PMID: 12771738

7

Positive prostate biopsy laterality and implications for staging.

Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE, Pollack A. Buyyounouski MK, et al. Among authors: uzzo rg. Urology. 2003 Aug;62(2):298-303. doi: 10.1016/s0090-4295(03)00334-0. Urology. 2003. PMID: 12893339

8

Does short-term androgen deprivation substitute for radiation dose in the treatment of high-risk prostate cancer?

Nguyen KH, Horwitz EM, Hanlon AL, Uzzo RG, Pollack A. Nguyen KH, et al. Among authors: uzzo rg. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):377-83. doi: 10.1016/s0360-3016(03)00573-x. Int J Radiat Oncol Biol Phys. 2003. PMID: 12957248 Clinical Trial.

9

Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.

Pollack A, Hanlon A, Horwitz EM, Feigenberg S, Uzzo RG, Price RA. Pollack A, et al. Among authors: uzzo rg. World J Urol. 2003 Sep;21(4):200-8. doi: 10.1007/s00345-003-0356-x. Epub 2003 Sep 5. World J Urol. 2003. PMID: 12961097 Review.

10

Brachytherapy for prostate cancer: follow-up and management of treatment failures.

Horwitz EM, Uzzo RG, Miller N, Theodorescu D. Horwitz EM, et al. Among authors: uzzo rg. Urol Clin North Am. 2003 Nov;30(4):737-50, viii-ix. doi: 10.1016/s0094-0143(03)00059-4. Urol Clin North Am. 2003. PMID: 14680311 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

440 results

Search Page